Viewing Study NCT05482295


Ignite Creation Date: 2025-12-24 @ 1:41 PM
Ignite Modification Date: 2026-01-01 @ 11:31 AM
Study NCT ID: NCT05482295
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-06-06
First Post: 2022-07-29
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Immunogenicity and Safety Following In-House Recombinant Hepatitis B Vaccine in Indonesian Population (Phase III)
Sponsor: PT Bio Farma
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module